A nationwide estrogen patch shortage is leaving menopausal women without critical medication for hot flashes and night sweats. The shortage, expected to last through year-end, stems from a 72 percent surge in prescriptions between 2021 and fall 2025. The spike followed the FDA's November removal of a black-box warning linking hormone therapy to cancer and heart disease.

This shortage highlights the growing demand for menopause treatment as more women seek relief from debilitating symptoms. Medical record data from Epic Research shows prescriptions continue to climb after decades of under-treatment. The shift comes as celebrities and influencers openly discuss menopause, while new research has re-evaluated the safety profile of hormone therapy for younger women.

Doctors report the pendulum may be swinging too far, with some promoting estrogen for longevity rather than symptom relief. While hormone therapy remains the most effective treatment for hot flashes and night sweats, experts caution against using it for unproven benefits like dementia prevention. The shortage underscores the need for balanced messaging about hormone therapy's appropriate use while ensuring women who need treatment can access it.